Bio-Rad Laboratories BIO
NYSE BIO
$376.81 -3.31 (-0.87%)
As of: Sep 9, 2026 · 12:52 PM EDT

Bio-Rad Laboratories (BIO) Preferred Shares (2019)

Bio-Rad Laboratories' (BIO) quarterly Preferred Shares came in at $7.5 million in Q4 2019.

Analysis

Bio-Rad Laboratories (BIO) Preferred Shares (2019) Analysis & Trends

Bio-Rad Laboratories (BIO) has reported Preferred Shares for 1 consecutive years, with $7.5 million the latest figure, recorded in Q4 2019.

  • On a quarterly basis, Preferred Shares changed N/A year-over-year to $7.5 million in Q4 2019; TTM through Dec 2019 was $7.5 million, a N/A change from a year earlier, with the FY2024 full-year figure at $7.5 million, changed N/A from the prior year.
  • Preferred Shares was $7.5 million for Q4 2019 at Bio-Rad Laboratories.
  • Over five years, Preferred Shares peaked at $7.5 million in Q4 2019 and troughed at $7.5 million in Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Thermo Fisher Scientific 224.53 Bn 220.47 Bn 8.34 Bn -
2 Danaher 144.44 Bn 140.09 Bn 3.61 Bn -
3 Agilent Technologies 40.82 Bn 39.06 Bn 1.04 Bn -
4 Illumina 31.35 Bn 30.19 Bn 770.00 Mn -
5 Revvity 13.67 Bn 12.64 Bn 416.87 Mn -
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -
7 Bio-Rad Laboratories 10.08 Bn 8.46 Bn 345.80 Mn -
8 Repligen 9.46 Bn 8.45 Bn 110.04 Mn -
9 10x Genomics 8.66 Bn 8.11 Bn 112.50 Mn -
10 Bruker 8.29 Bn 8.07 Bn 416.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 7.50 Mn